102 related articles for article (PubMed ID: 704769)
1. Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
Friedhoff AJ; Rosengarten H; Bonnet K
Psychopharmacol Bull; 1978 Oct; 14(4):77-9. PubMed ID: 704769
[No Abstract] [Full Text] [Related]
2. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Shoulson I
Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
[No Abstract] [Full Text] [Related]
3. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Bitton V; Melamed E
J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
[TBL] [Abstract][Full Text] [Related]
4. Dopamine agonists in clinical research for new tardive dyskinesia treatments.
Gerlach J; Casey DE
Mod Probl Pharmacopsychiatry; 1983; 21():97-110. PubMed ID: 6140637
[No Abstract] [Full Text] [Related]
5. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
Alpert M; Friedhoff AJ; Diamond F
Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
[No Abstract] [Full Text] [Related]
6. Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Goetz CG; Klawans HL; Carvey P
Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633
[No Abstract] [Full Text] [Related]
7. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Ringwald E
Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
[TBL] [Abstract][Full Text] [Related]
8. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
9. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
Simpson GM; Yadalam KG; Stephanos MJ
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
[TBL] [Abstract][Full Text] [Related]
10. Drug therapy for Parkinsonism.
Walker E
Mod Healthc (Short Term Care); 1976 Jan; 5(1):62. PubMed ID: 1652
[No Abstract] [Full Text] [Related]
11. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
Savery F
Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
[No Abstract] [Full Text] [Related]
12. Sinemet.
Drug Ther Bull; 1974 Oct; 12(21):83-4. PubMed ID: 4617660
[No Abstract] [Full Text] [Related]
13. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
Hayek J
Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
16. Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
Savola JM; Hill M; Engstrom M; Merivuori H; Wurster S; McGuire SG; Fox SH; Crossman AR; Brotchie JM
Mov Disord; 2003 Aug; 18(8):872-83. PubMed ID: 12889076
[TBL] [Abstract][Full Text] [Related]
17. Cyproheptadine in levodopa-induced dyskinesia in parkinsonism.
Papavasilliou PS; Cotzias GC; McDowell FH; Rosal VL; Sheehan PJ
Clin Pharmacol Ther; 1978 Feb; 23(2):195-8. PubMed ID: 620480
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
Kamenetskiĭ VK
Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
[No Abstract] [Full Text] [Related]
19. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
20. Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model [proceedings].
Rubovits R
Psychopharmacol Bull; 1977 Jan; 13(1):49-50. PubMed ID: 402011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
